Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-12 | Intra-Cellular Therapies, Inc. | Halstead Michael
(President) |
S | Common Stock | D | 41583 | $88.17 - $90.89 | $3,692,098 |
| 2024-11-12 | Intra-Cellular Therapies, Inc. | Halstead Michael
(President) |
M | Common Stock | A | 41583 | $23.94 - $36.89 | $1,237,842 |
| 2024-09-30 | Intra-Cellular Therapies, Inc. | RIGGS RORY B
(Director) |
A | Common Stock | A | 246 | $73.17 - $73.17 | $17,999 |
| 2024-08-29 | Intra-Cellular Therapies, Inc. | Mates Sharon
(Chairman and CEO) |
S | Common Stock | D | 70000 | $72.44 - $73.32 | $5,089,233 |
| 2024-08-29 | Intra-Cellular Therapies, Inc. | Mates Sharon
(Chairman and CEO) |
M | Common Stock | A | 70000 | $12.73 - $12.73 | $891,099 |
| 2024-08-26 | Intra-Cellular Therapies, Inc. | Mates Sharon
(Chairman and CEO) |
S | Common Stock | D | 95925 | $72.74 - $74.59 | $7,054,084 |
| 2024-08-26 | Intra-Cellular Therapies, Inc. | Mates Sharon
(Chairman and CEO) |
M | Common Stock | A | 95925 | $17.57 - $17.57 | $1,685,401 |
| 2024-08-21 | Intra-Cellular Therapies, Inc. | Mates Sharon
(Chairman and CEO) |
S | Common Stock | D | 121073 | $74.46 - $77.98 | $9,086,734 |
| 2024-08-21 | Intra-Cellular Therapies, Inc. | Mates Sharon
(Chairman and CEO) |
M | Common Stock | A | 121073 | $17.57 - $17.57 | $2,127,251 |
| 2024-08-16 | Intra-Cellular Therapies, Inc. | Neumann Mark
(EVP, Chief Commercial Officer) |
S | Common Stock | D | 18714 | $75.08 - $75.08 | $1,405,047 |
| 2024-08-16 | Intra-Cellular Therapies, Inc. | Neumann Mark
(EVP, Chief Commercial Officer) |
M | Common Stock | A | 18714 | $36.89 - $36.89 | $690,359 |
| 2024-06-28 | Intra-Cellular Therapies, Inc. | VAN NOSTRAND ROBE...
(Director) |
A | Common Stock | A | 83 | $68.49 - $68.49 | $5,684 |
| 2024-06-28 | Intra-Cellular Therapies, Inc. | RIGGS RORY B
(Director) |
A | Common Stock | A | 262 | $68.49 - $68.49 | $17,944 |
| 2024-06-24 | Intra-Cellular Therapies, Inc. | RIGGS RORY B
(Director) |
S | Common Stock | D | 4462 | $75.57 - $75.57 | $337,193 |
| 2024-06-24 | Intra-Cellular Therapies, Inc. | RIGGS RORY B
(Director) |
M | Common Stock | A | 20000 | $16.86 - $16.86 | $337,200 |
| 2024-06-18 | Intra-Cellular Therapies, Inc. | VAN NOSTRAND ROBE...
(Director) |
S | Common Stock | D | 20000 | $75.71 - $76.07 | $1,518,198 |
| 2024-06-18 | Intra-Cellular Therapies, Inc. | VAN NOSTRAND ROBE...
(Director) |
M | Common Stock | A | 20000 | $16.86 - $16.86 | $337,200 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |